These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4844244)

  • 21. DOM (STP), a new hallucinogenic drug: specific perceptual changes.
    Weingartner H; Snyder SH; Faillace LA
    J Clin Pharmacol New Drugs; 1971; 11(2):103-11. PubMed ID: 5206471
    [No Abstract]   [Full Text] [Related]  

  • 22. The effects of 2,5-dimethoxy-4-methylamphetamine (DOM) on operant behavior: interactions with other neuroactive agents.
    Commissaris RL; Semeyn DR; Moore KE; Rech RH
    Commun Psychopharmacol; 1980; 4(5):393-404. PubMed ID: 6120791
    [No Abstract]   [Full Text] [Related]  

  • 23. The time-dependent stimulus effects of R(-)-2,5-dimethoxy-4-methamphetamine (DOM): implications for drug-induced stimulus control as a method for the study of hallucinogenic agents.
    Fiorella D; Palumbo PA; Rabin RA; Winter JC
    Psychopharmacology (Berl); 1995 May; 119(2):239-45. PubMed ID: 7659772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of 2,5-dimethoxy-4-methylamphetamine (DOM, STP) on the uptake and release of 14C-5-hydroxytryptamine by rabbit blood platelets.
    Huang JT; Airaksinen MM; Ho BT
    Eur J Pharmacol; 1974 Feb; 25(2):251-4. PubMed ID: 4435028
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis and evaluation of 2,3-dihydrobenzofuran analogues of the hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane: drug discrimination studies in rats.
    Nichols DE; Hoffman AJ; Oberlender RA; Riggs RM
    J Med Chem; 1986 Feb; 29(2):302-4. PubMed ID: 3950910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral changes induced by 2,5-dimethoxy 4-methyl-amphetamine (DOM, STP) in primate dyads.
    Tyler CB; Schlemmer RF; Narasimhachari N; Davis JM
    Commun Psychopharmacol; 1978; 2(4):337-42. PubMed ID: 103677
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of Ketanserin, M100907 and Olanzapine on hallucinogenic like action induced by 2,5-dimethoxy-4-methylamphetamine.
    Li K; Liu X; Zhang M; Su R
    Behav Pharmacol; 2023 Apr; 34(2-3):92-100. PubMed ID: 36752335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of d-lysergic acid diethylamide, d-2-bromolysergic acid diethylamide, dl-2,5-dimethoxy-4-methylamphetamine and d-amphetamine on classical conditioning of the rabbit nictitating membrane response.
    Harvey JA; Gormezano I; Cool VA
    J Pharmacol Exp Ther; 1982 May; 221(2):289-94. PubMed ID: 6122729
    [No Abstract]   [Full Text] [Related]  

  • 29. A characteristic effect of hallucinogens on investigatory responding in rats.
    Geyer MA; Light RK; Rose GJ; Petersen LR; Horwitt DD; Adams LM; Hawkins RL
    Psychopharmacology (Berl); 1979 Sep; 65(1):35-40. PubMed ID: 116288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents.
    Glennon RA; Titeler M; McKenney JD
    Life Sci; 1984 Dec; 35(25):2505-11. PubMed ID: 6513725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative effects of hallucinogenic drugs on behavior of the cat.
    Jacobs BL; Trulson ME; Stark AD; Christoph GR
    Commun Psychopharmacol; 1977; 1(3):243-54. PubMed ID: 272265
    [No Abstract]   [Full Text] [Related]  

  • 32. Some effects of the hallucinogenic drug 2, 5-dimethoxy-4-methyl amphetamine on the metabolism of biogenic amines in the rat brain.
    Leonard BE
    Psychopharmacologia; 1973 Aug; 32(1):33-49. PubMed ID: 4743235
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of clozapine and 2,5-dimethoxy-4-methylamphetamine [DOM] on 5-HT2A receptor expression in discrete brain areas.
    Doat-Meyerhoefer MM; Hard R; Winter JC; Rabin RA
    Pharmacol Biochem Behav; 2005 Aug; 81(4):750-7. PubMed ID: 15972234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. II: Reassessment of LSD false positives.
    Fiorella D; Rabin RA; Winter JC
    Psychopharmacology (Berl); 1995 Oct; 121(3):357-63. PubMed ID: 8584618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A crystallographic and theoretical study of the conformation of DOET and its significance for the hallucinogenic amphetamines.
    Horn AS; Post ML; Kennard O; Di Sanserverino R
    J Pharm Pharmacol; 1975 Jan; 27(1):13-7. PubMed ID: 235609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents.
    Gatch MB; Dolan SB; Forster MJ
    Behav Pharmacol; 2017 Aug; 28(5):375-385. PubMed ID: 28537942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral comparisons of R-2-amino-1-(2,5-dimethoxy-4-methylphenyl) butane (BL-3912A) with R-DOM and S-amphetamine.
    Tilson HA; Chamberlain JH; Gylys JA
    Psychopharmacology (Berl); 1977 Jan; 51(2):169-73. PubMed ID: 402669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible involvement of serotonin receptors in the facilitatory effect of a hallucinogenic phenethylamine on single facial motoneurons.
    Penington NJ; Reiffenstein RJ
    Can J Physiol Pharmacol; 1986 Oct; 64(10):1302-9. PubMed ID: 3801984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Drug dependence. A review of the narcotic and hallucinogenic effects of drugs].
    Haan J
    Med Monatsschr Pharm; 1981 May; 4(5):129-37. PubMed ID: 7024769
    [No Abstract]   [Full Text] [Related]  

  • 40. Indolealkylamine and phenalkylamine hallucinogens. Effect of alpha-methyl and N-methyl substituents on behavioral activity.
    Glennon RA; Young R; Jacyno JM
    Biochem Pharmacol; 1983 Apr; 32(7):1267-73. PubMed ID: 6573879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.